Global Clinical Trials Connect 2020: Futuristic Advancements in Clinical Trials and Clinical Research (London, UK – May 13-14, 2020)

Dublin, Feb. 12, 2020 (GLOBE NEWSWIRE) — The “Global Clinical Trials Connect 2020” conference has been added to ResearchAndMarkets.com’s offering.
The 4th Annual Global Clinical Trials Connect 2020 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.Patient Recruitment and Site selectionInnovative trial designsPartnership & Collaboration – Sponsors, CROs, Sites and External VendorsPatient-centric clinical trialsMaking Patient Engagement a RealityNew innovations in Patient Recruitment planning and execution on a clinical trialOutsourcing strategies and modelsElectronic Clinical Outcome Assessment and Electronic Patient Reported OutcomeStreamlined IRT development processPharmacovigilance & Clinical TrialsPost-Clinical Trial closed communitiesHow to future proof your clinical operationsImplementing Risk-Based MonitoringStreamlining R&D and lower costs in clinical trialsAdaptive Trial ModelClinical Trial AuditingReal-World Clinical Trial StrategiesData Quality & TechnologyClinical Data Strategy & AnalyticsClinical Technology and Driving InnovationM-Health, Wearable and Consumer TechnologyBig-Data, IoT and Artificial Intelligence in Clinical trialsBlockchain technology for improving clinical research qualityAgenda
DAY 108:30 – Registration & RefreshmentsConnecting the developed and the developing nationsDealing with differences owing to culture and ethnicityRole of CROs and third-party stakeholders10:00 – Innovative trial designs to save time and cost without compromising on the efficiencyStrategies & Methods for flexible design trialsThe Adoption and Impact of Adaptive Trial DesignsPreclinical environment and trial designs Opportunities and Limitations10:30 – Morning Coffee/Tea & NetworkingInform/de-risk phase IIIProof of ConceptEnrich patient populationLabel enhancementPatient Recruitment & Site SelectionNew approach to strategic recruitment planningCo-operation with all relevant stakeholdersData-driven approach to maximize engagement and supportRecruitment performance monitoring and evaluation planPatient-Centric Enrolments Planning and Engagement11:50 – Monitoring and Quality Assurance in site selection and patient recruitment to optimize clinical trialsSite pre-assessment and selectionEnsure patient protection and to deliver high quality dataQuality assurance can at times be difficult as regulatory requirements, standards and access to care differ globally – How are we going to handle this?12:20 – Networking & LuncheonPatient recruitment and engagement toolsChallenges and Barriers – How to overcome it?New models will have to emerge to support data sharing while protecting patient privacyHow to tackle the lack of regulatory guidance?13:40 – Effective patient recruitment and retention in clinical trialsWhat will persuade and impact the patient?Is there anything pharma can provide for a trial member that will increase the value of participation?The aim of patient-driven clinical trials is to diminish the burden of participation by making the participant journey as convenient and pleasant as possibleUtilize fitting procedures and techniques to limit dropouts without, in any capacity, constraining a patient to remain in the study14:10 – Panel discussion: Novel approaches to streamline site selection and reduce delay in recruitment to ensure successDiscover sites with a demonstrated track record of good execution in trialsStudy and site staff with solid certifications to expand the likelihood of powerful enrolment and an effective trial.Factors such as disease prevalence rates, treatment practices, regulatory requirements and statistical considerations must be consideredAccess to subject population with the required eligibility criteriaNetwork within industriesPatient Centricity & Patient EngagementCurrent trends & challengesUnderstanding of the patient and the trial journeyImproving data quality and ensure safety & efficacyEngaging and retaining existing patientsImproving patient centricity of the trialsIntegrating technology and communication to enhance transparency15:10 – Afternoon Tea/CoffeeExamine learning points from multiple studies engaging patients at the protocol design stageUnderstand the importance of the independent intermediaryAnalyse the outcomes – evidencing the impact of earlier involvement16:00 – Aspects of Informed Consent and Vulnerable Patients in Clinical Trials in the Digital AgePatient-centric remote trials trial settingCustomization of clinical trialsSimplify trial participation.Modern technology for collecting clinical dataDirect Data Capture (DDC)Experiences from current trials, challenges and benefits17:00 – Interactive Breakout Discussions:Round Table 1: Innovation in Clinical Trials – Digital ApproachesRound Table 2: Patient CentricityRound Table 3: Globalization and Country SpecificsRound Table 4: Recruitment Challenges – Patients and SitesRound Table 5: Changing Clinical Trials – What needs to be addressedRound Table 6: Patient Retention17:30 – Chairperson’s closing remarksDAY 2Flexible, and easy to implement modelCreating an effective strategy to decide when to outsourceAnalysing the key risk factors your CRO might bring and how to tackle them09:30 – Establishing quality partnerships between sponsors and CROsHaving a shared vision in sponsor-vendor relationshipsInvolving the CRO in the project design and planningDecide on the Quality Agreement and CRO Oversight Plan upfront10:00 – Efficient means of vendor oversight when it comes to metrics, deliverables and qualityMonitoring outsourced clinical trialsManaging Continuous & Real-Time CollaborationBoth sponsor and CRO must invest time in defining goals, anticipating issues and measuring results.10:30 – Morning Coffee/Tea & DiscussionManaging continuous & real-time collaborationHow transparency will lead to industrywide collaborationBoth sponsor and CRO must invest time in defining goals, anticipating issues and measuring results.Considering what patient centricity factors your CRO brings in12:20 – Networking & LuncheonObserving exercises and methodologies ought to be chosen to be proportionate to the risks identified within a trial.Risk-based monitoring needs an effective and adaptable technology platform with analytics, which are combined with monitoring to assess, manage and mitigate risk.Clinical Data and Tech-Driven TrialsInnovative trial designsPatient Recruitment and Site selectionImplementing Risk-Based Monitoring15:10 – Afternoon Tea/CoffeeStrategies for better decision-makingHigh-level models and simulations compelled by data will allow the elimination of risky trialsThe potential of real-world data in clinical research goes past patient identification and patient recruitment16:00 – Clinical trials in the era of digitization – the impact of smart innovations in clinical researchRethinking the R&D Clinical ProcessPatient-Centred Innovation in Clinical TrialsNew trial designs and analysis methodsDiscovering and validating sequential, personalized decision-making strategiesAn Integrated Business Model – Using technology to streamline processes16:30 – Describing the landscape in the pharma and healthcare settings, exploring the areas where Blockchain could be used and presenting two detailed use casesPatient Data Access/Transparency) to support future development and implementation for an upcoming proof of concept.Drug Supply Chain using Smart Contracts17:00 – Novel techniques- Tech-driven clinical trialsEffectively using technology is enabling patient centricityHow to implement mobile technology and make it work in clinical trialsDoes consumer technology devices used in clinical trials?IoT in digital transformation of clinical trials17:30 – Chairperson’s closing remarksFor more information about this conference visit https://www.researchandmarkets.com/r/vdr05iResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900